Hyungsuk Kim

Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia

Measurable residual disease (MRD) is a key prognostic marker in B-lymphoblastic leukemia (B-ALL). Because immunophenotypic and cytogenetic features vary by genetic subtype and treatment phase, the clinical value of an integrated MRD strategy using multiparametric flow cytometry (...